Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Financial Officer sold 10,099 shares at $287.46 ($2,903,059)
  6. 4 Open-market sale Director sold 274,092 shares at $287.46 ($78,790,486)
  7. 4 Open-market sale Chief Executive Officer sold 73,526 shares at $287.46 ($21,135,784)
  8. 4 Open-market sale Chief Medical Officer, EVP R&D sold 73,526 shares at $287.46 ($21,135,784)
  9. 4 Open-market sale Director sold 280,000 shares at $287.46 ($80,488,800)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 2,000 shares at an average $16.12 ($32,236)
  14. 4 Open-market buy Director bought 3,550 shares at an average $16.12 ($57,209)
  15. 4 Open-market buy Director bought 3,550 shares at an average $15.88 ($56,358)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 29 · 564 filings